# Terren Peizer

> Terren Peizer is a Series A investor at BioVie backing Blockchain and Enterprise Software. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioVie](https://shizune.co/investors/profile/biovie)
- Location: Santa Monica, United States
- Total investments: 1
- Last investment: Sep 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/terren-peizer-390b59a
- X (Twitter): https://twitter.com/terrenpeizer
- Website: http://en.wikipedia.org/wiki/Terren_Peizer
- Facebook: https://www.facebook.com/terren1

Terren Peizer is a Series A investor at BioVie in Santa Monica focused on Blockchain and Enterprise Software. Terren Peizer is the Founder, Chairman and CEO of Ontrak Health. He previously worked at Drexel Burnham Lambert as a Senior Vice President. Terren Peizer attended The Wharton School.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Blockchain | 1 | 100% |
| Enterprise Software | 1 | 100% |
| Information Technology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Casper Labs | Casper Labs provides professional services and support for organizations building on Casper, the first enterprise-grade blockchain. Guided by open source principles, CasperLabs is committed to supporting the next wave of blockchain adoption among businesses and providing developers with a reliable and secure framework to build private, public, andhybrid solutions and applications. | $14.5M | Series A | Sep 10, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [Arrington XRP Capital](https://shizune.co/investors/profile/arrington-capital) — VC Fund, 1 deal together
- [Arrington XRP Capital](https://shizune.co/investors/profile/arrington-xrp-capital) — VC Fund, 1 deal together
- [AU21 Capital](https://shizune.co/investors/profile/au21-capital) — VC Fund, 1 deal together
- [Blockchange Ventures](https://shizune.co/investors/profile/blockchange-ventures) — VC Fund, 1 deal together
- [Consensus Capital Holdings](https://shizune.co/investors/profile/consensus-capital-holdings) — VC Fund, 1 deal together
- [Hashkey Exchange](https://shizune.co/investors/profile/hashkey) — VC Fund, 1 deal together

## About BioVie

VC Fund · Beverly, United States

BioVie is pioneering an innovative therapeutic approach targeting ascites due to liver cirrhosis. Ascites, or the accumulation of fluid in the abdomen, is the most common complication of cirrhosis due to NASH (non-alcoholic steatohepatitis), alcoholic liver disease and/or hepatitis C. Ascites affects about 100,000 Americans and many timesmore worldwide, and contributes substantially to mortality. Our therapy BIV201 is based on a drug that is not yet available in the US but is approved in about 50 countries to treat related complications of liver cirrhosis.The Company, formerly knows as NanoAntibiotics, Inc., recently acquired LAT Pharma LLC. This merger provided our lead development program, BIV201. Following a pre-investigational new drug meeting (“pre-IND”) with the FDA in early 2016, the Company is now assembling its IND package, and may commence a US clinical trial as early as 2017.

5 contacts available at BioVie.

| Name | Title | Profile |
| --- | --- | --- |
| Amrit Shahzad | President | https://shizune.co/investors/profile/amrit-shahzad |
| Elliot Ehrlich | Chief Executive Officer | https://shizune.co/investors/profile/elliot-ehrlich |
| Jonathan Adams | Chief Executive Officer; President & COO | https://shizune.co/investors/profile/jonathan-adams-4 |
| Joseph M. Palumbo | CMO | https://shizune.co/investors/profile/joseph-m-palumbo |
| Penelope Markham | Chief Scientific Officer | https://shizune.co/investors/profile/penelope-markham |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Terren Peizer invest in?

Terren Peizer invests primarily in Blockchain, Enterprise Software and Information Technology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Terren Peizer last invest?

The most recent investment recorded for Terren Peizer closed in Sep 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co